Alzheimer's disease pipeline

ad-pd-2025-conference-highlights

Apr 18, 2025

Groundbreaking Alzheimer’s Therapies: From Pipeline to Patient Care

Alzheimer’s Treatment Latest Breakthroughs and Advancements in Therapeutic Development

Feb 26, 2025

Alzheimer’s Treatment: Latest Breakthroughs and Advancements in Therapeutic Development

Semaglutide A Potential Game-Changer in Reducing Alzheimer's Disease Risk

Feb 12, 2025

Semaglutide: A Potential Game-Changer in Reducing Alzheimer’s Disease Risk

Can Remternetug Solve the Puzzle of Alzheimer’s

Feb 12, 2025

Can Remternetug Solve the Puzzle of Alzheimer’s?

What is the link between Alzheimer’s and Menopause

Feb 12, 2025

What is the Link Between Alzheimer’s and Menopause?

Exploring the Current Alzheimer's Disease Drug Development Pipeline

Feb 12, 2025

Exploring the Current Alzheimer’s Disease Drug Development Pipeline

LEQEMBI A New Hope for Alzheimer’s Disease Patients

Feb 12, 2025

LEQEMBI: A New Hope for Alzheimer’s Disease Patients

kinsunla-for-alzheimer-disease-treatment

Jul 08, 2024

A New Dawn in Alzheimer’s Disease Treatment: Eli Lilly’s Donanemab Wins FDA Approval

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper